Podcast

Ilya Kister, MD, on the Risks of Stopping MS Disease-Modifying Therapies

11/14/2018

Ilya Kister, MD, from NYU Langone Health, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying therapies.

Ilya Kister, MD, is an associate professor in the Department of Neurology at NYU Langone Health in New York City.

Related Content

Vascular Disease
Vascular Disease
Peter Libby, MD, on Clonal Hematopoiesis of Indeterminate Potential and Atherosclerosis
03/04/2020
In this podcast, Peter Libby, MD, from Brigham and Women’s Hospital and Harvard Medical School, gives an overview of clonal hematopoiesis of indeterminate potential, how it relates to cardiovascular...
03/04/2020
Osteoporosis
Osteoporosis
Sonali Thosani, MD, on Bone Health Among Long-Term Cancer Survivors
09/12/2019
Dr Thosani, from The University of Texas MD Anderson Cancer Center, discusses the management of bone health among long-term cancer survivors, the importance of osteoporosis screening, and more.
09/12/2019
Cardiometabolic Risk
Cardiometabolic Risk
Donna Ryan, MD, MABOM, on Evaluating Obesity Medications
10/01/2019
She talks about evaluating obesity medications, her tips for choosing the right medication for the right patient, and medications that are on the horizon. This is also the topic of her session at our...
10/01/2019
Alzheimer Disease
Alzheimer Disease
David Llewellyn, MD, on the Bias in Cognitive Assessments
02/04/2019
Dr David Llewellyn from the University of Exeter Medical School answers our questions about his research on dementia misclassification when using brief cognitive assessments.
02/04/2019
treatment
treatment
Brooke Nichols, PhD, on Measuring PrEP Program Effectiveness Using Routine Data
03/17/2022
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine...
03/17/2022